StockData
Greenwich LifeSciences, Inc. logo

Greenwich LifeSciences, Inc. (GLSI) KPIs and segments

GLSINasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026Score 5/30
$18.70+4.94 (+35.90%)

Close on Nov 17, 2026Market cap $274.48MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Greenwich LifeSciences's business

Coming soon

This tab will track the numbers specific to Greenwich LifeSciences's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?